Radrizzani, M <br/><br/>
Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  1989 
 - 233-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-7004 
<br/><br/><label>Standard No.: </label>10.1007/BF01665010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigen-Presenting Cells--physiology<br/>Antigens, CD--analysis<br/>Antigens, Differentiation, T-Lymphocyte--analysis<br/>CD3 Complex<br/>CD4 Antigens--analysis<br/>CD4-Positive T-Lymphocytes--immunology<br/>Humans<br/>Interleukin-2--pharmacology<br/>Lymphocyte Activation<br/>Neoplasms--immunology<br/>Phenotype<br/>Receptors, Antigen, T-Cell--analysis<br/>T-Lymphocytes--immunology